Part of the Metabolic & Hormonal Health Knowledge Library
How Does Ayurveda Help You Cope with IBS?
Living with Irritable Bowel Syndrome (IBS) often feels like walking on eggshells—every meal, every stressor, and every slight change in routine can trigger discomfort (Mearin et al., 2016). The condition affects not only gastrointestinal health but also emotional well-being, sleep quality, and social life. While conventional treatments focus on managing symptoms, they rarely address the underlying causes of IBS, leaving patients seeking a more sustainable and holistic solution.
Ayurveda, the ancient holistic science of healing, offers a unique perspective by targeting the root causes, restoring balance in the body, and improving digestive health. At EliteAyurveda, we provide personalized Ayurvedic care to help individuals achieve long-term relief from IBS, regain control over their lives, and restore overall well-being (Frawley, 2000; Lad, 2002; Pole, 2013).
How Does Ayurveda Help You Cope with IBS
In Ayurveda, IBS is understood through the concept of Grahani, a disorder affecting the digestive fire (Agni) and the stability of the gastrointestinal tract. IBS arises from imbalances in Vata, Pitta, and Kapha doshas, each contributing differently to the symptoms:
Weak digestion and toxin (Ama) accumulation further exacerbate these doshic imbalances, leading to persistent discomfort and unpredictable flare-ups (Sharma et al., 2007).
IBS is not solely a physical condition; it impacts emotional health and daily functioning (Mearin et al., 2016):
Ayurveda acknowledges these struggles and aims to restore balance, offering a pathway to both physical and emotional resilience.
Ayurveda addresses IBS by improving digestion, detoxifying the system, and restoring doshic balance. Treatments are tailored to each individual’s constitution (Prakriti) and unique symptoms.
Toxins impair digestion and worsen IBS symptoms. Ayurvedic detoxification therapies clear these toxins and promote gut health (Sharma et al., 2007):
Ayurvedic herbal formulations are individualized to strengthen digestion and address specific IBS subtypes:
These personalized herbal medications support gut health and prevent recurring IBS symptoms (Frawley, 2000).
Diet plays a pivotal role in Ayurvedic IBS management:
Lifestyle practices form the foundation of long-term IBS management in Ayurveda:
Weak digestion is a root cause of IBS. Ayurveda enhances Agni to prevent toxin buildup and ensure proper nutrient absorption (Pole, 2013):
Patient Profile:
Treatment Plan at EliteAyurveda:
Outcome:
Coping with IBS can feel overwhelming, but Ayurveda offers a natural, enduring approach. By addressing underlying imbalances, improving digestion, and emphasizing emotional support, Ayurveda helps individuals achieve lasting relief and regain their sense of control and comfort.
At EliteAyurveda, we guide patients through this journey with compassionate, personalized Ayurvedic care.
Take the first step toward better gut health today.📞 Contact us at +91 8884722246🌐 Visit: www.eliteayurveda.com
Related-
Know More About Ayurveda Treatment for irritable bowel syndrome.
GET IN TOUCH
Contact us
1.Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. (2012) 10:712–21.e4. 10.1016/j.cgh.2012.02.029 [DOI] [PubMed] [Google Scholar]
2.Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. (2017) 376:2566–78. 10.1056/NEJMra1607547 [DOI] [PubMed] [Google Scholar]
3.Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol. (2007) 102:2767–76. 10.1111/j.1572-0241.2007.01540.x [DOI] [PubMed] [Google Scholar]
4.Agarwal N, Spiegel BM. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin North Am. (2011) 40:11–9. 10.1016/j.gtc.2010.12.013 [DOI] [PubMed] [Google Scholar]
5.Lacy BE. The science, evidence, and practice of dietary interventions in irritable bowel syndrome. Clin Gastroenterol Hepatol. (2015) 13:1899–906. 10.1016/j.cgh.2015.02.043 [DOI] [PubMed] [Google Scholar]
6.Hill P, Muir JG, Gibson PR. Controversies and recent developments of the low-FODMAP diet. Gastroenterol Hepatol. (2017) 13:36–45. [PMC free article] [PubMed] [Google Scholar]
7.World Health Organization . WHO Traditional Medicine Strategy 2014-2023. (2013). Available online at: http://www.who.int/medicines/publications/traditional/trm\_strategy14\_23/en/ (assessed March 10, 2021).
8.Sharma H, Chandola HM. Ayurvedic concept of obesity, metabolic syndrome, and diabetes mellitus. J Altern Complement Med. (2011) 17:549–52. 10.1089/acm.2010.0690 [DOI] [PubMed] [Google Scholar]
9.Kessler CS, Morandi A, Kumar A, Dhiman KS, Gupta S, Icke K, et al. Reliability of ayurvedic diagnosis for knee osteoarthritis patients: a nested diagnostic study within a randomized controlled trial. J Altern Complement Med. (2019) 25:910–9. 10.1089/acm.2018.0273 [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Sharma RK, Dash VB. Caraka Samhita: Chowkhamba Sanskrit Series. Varanasi: Chowkhamba Sanskrit Series Office; (2009). [Google Scholar]
11.Gupta SN, Stapelfeldt E. Ayurveda-Medizin: kaya-cikitsa – Therapiekonzepte für innere Erkrankungen Thieme. Thieme: (2019). [Google Scholar]
12.Layer P, Andresen V, Pehl C, Allescher H, Bischoff SC, Classen M, et al. Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management. Z Gastroenterol. (2011) 49:237–93. 10.1055/s-0029-1245976 [DOI] [PubMed] [Google Scholar]
13.Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P. Irritable bowel syndrome. Dtsch Arztebl Int. (2011) 108:751–60. 10.3238/arztebl.2011.0751 [DOI] [PMC free article] [PubMed] [Google Scholar]
14.Betz C, Mannsdorfer K, Bischoff SC. Validation of the IBS-SSS. Z Gastroenterol. (2013) 51:1171–6. 10.1055/s-0033-1335260 [DOI] [PubMed] [Google Scholar]
15.Drossman DA, Patrick DL, Whitehead WE, Toner BB, Diamant NE, Hu Y, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. (2000) 95:999–1007. 10.1111/j.1572-0241.2000.01941.x [DOI] [PubMed] [Google Scholar]
16.Topp CW, Ostergaard SD, Sondergaard S, Bech P. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. (2015) 84:167–76. 10.1159/000376585 [DOI] [PubMed] [Google Scholar]
17.Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. (1983) 24:385–96. 10.2307/2136404 [DOI] [PubMed] [Google Scholar]
18.Herrmann-Lingen C, Buss U, Snaith R. Hospital Anxiety and Depression Scale – Deutsche Version (HADS-D) (3., aktualisierte und neu normierte Auflage). Manual. Bern: Hans Huber; (2011). [Google Scholar]
19.Caraka Samhita. In: Sharma RK, Bhagwan Dash V, editors. Vimānasthāna 124f and 22-7; Sutrasthāna 2533-36; 273 and 331-350; 281-7; Cikitsāsthāna 1542-44 and 235-243. Chowkhamba Sanskrit Series; (2009). [Google Scholar]
20.Caraka Samhita. In: Sharma RK, Bhagwan Dash V, editors. Sutrasthāna 2538-40; 2642-84; 27; Cikitsāsthāna 1914-33. Chowkhamba Sanskrit Series; (2009). [Google Scholar]
21.Cremer M, Köhnke K. Essen und Trinken beim Reizdarmsyndrom [Eating and drinking in irritable bowel syndrome] Bonn: The German Nutrition Society (Deutsche Gesellschaft für Ernährung e. V.) (2013). Available online at: https://www.dge.de/presse/pm/essen-und-trinken-beim-reizdarmsyndrom/ (assessed March 10, 2021).
22.Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR, Clinical Significance Consensus Meeting G . Methods to explain the clinical significance of health status measures. Mayo Clin Proc. (2002) 77:371–83. 10.4065/77.4.371 [DOI] [PubMed] [Google Scholar]
23.Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. (1997) 11:395–402. 10.1046/j.1365-2036.1997.142318000.x [DOI] [PubMed] [Google Scholar]
24.Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. (2015) 12:472–85. 10.1038/nrgastro.2015.117 [DOI] [PubMed] [Google Scholar]
25.Dorn SD, Kaptchuk TJ, Park JB, Nguyen LT, Canenguez K, Nam BH, et al. A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol Motil. (2007) 19:630–7. 10.1111/j.1365-2982.2007.00937.x [DOI] [PubMed] [Google Scholar]
26.Patel SM, Stason WB, Legedza A, Ock SM, Kaptchuk TJ, Conboy L, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. (2005) 17:332–40. 10.1111/j.1365-2982.2005.00650.x [DOI] [PubMed] [Google Scholar]
27.Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr. (2016) 55:897–906. 10.1007/s00394-015-0922-1 [DOI] [PubMed] [Google Scholar]
28.McKenzie YA, Bowyer RK, Leach H, Gulia P, Horobin J, O’Sullivan NA, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. (2016) 29:549–75. 10.1111/jhn.12385 [DOI] [PubMed] [Google Scholar]
29.Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. (2017) 66:1517–27. 10.1136/gutjnl-2017-313750 [DOI] [PubMed] [Google Scholar]
30.Schumann D, Klose P, Lauche R, Dobos G, Langhorst J, Cramer H. Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Nutrition. (2018) 45:24–31. 10.1016/j.nut.2017.07.004 [DOI] [PubMed] [Google Scholar]
31.Lauche R, Kumar S, Hallmann J, Ludtke R, Rampp T, Dobos G, et al. Efficacy and safety of Ayurvedic herbs in diarrhoea-predominant irritable bowel syndrome: a randomised controlled crossover trial. Complement Ther Med. (2016) 26:171–7. 10.1016/j.ctim.2016.04.002 [DOI] [PubMed] [Google Scholar]
Medical disclaimer. This article is for general information and is not a substitute for personalised medical advice. Ayurvedic treatment at EliteAyurveda is individualised following clinical assessment. Do not start, stop or alter any prescribed medication without consulting your treating physician.